drug resistance

Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy

New Research Consortium to Standardize Single-Cell Sequencing for Cancer Drug Resistance Studies

Breast Cancer Genomics Study Reveals Recurrent Contributors to Treatment Resistance in Early Disease

OncoHost Raises $8 Million in Series B Funding Round

Real-World Data Reinforces Survival Benefit of Sequential Gilotrif, Tagrisso in EGFR-Mutated NSCLC

JS InnoPharm Doses First Patient in Phase I Trial of ERK Inhibitor JSI-1187

Bridge Biotherapeutics' IND for EGFR Inhibitor Accepted by South Korean Regulators

Glioma Hypermutation May Not Correspond to Checkpoint Immunotherapy Response, Study Suggests

Mutations in PTEN, ESR1 Promote Piqray Resistance in HR-Positive Breast Cancer, Study Finds

Hansoh Pharma's EGFR-Mutated Lung Cancer Drug Gains Market Authorization in China

Integrated Genomic Analysis Highlights Potential Strategy for Overcoming Some ALL Resistance

Small-Cell Lung Cancers Become Molecularly Heterogeneous With Treatment, Study Shows

FDA Accepts Bridge Biotherapeutics' Investigational New Drug Application for Lung Cancer Drug

Bridge Biotherapeutics Files IND for Lung Cancer Drug Targeting EGFR Resistance Mutation

PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial